Haleon PLC (HLN)

Industry Drug Manufacturers - Specialty & Generic
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

331.00p

Buy

331.20p

arrow-up3.80p (+1.15%)

Prices updated at 15 May 2026, 17:00 BST
| Prices minimum 15 mins delay
|
Prices in GBX
FTSE All-Share
arrow-down-1.63%
LSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Chairman
Mr. Manvinder Singh Banga
CEO
Mr. Brian James McNamara
Most recent earnings
31 Dec 2025
Fiscal year end
31 Dec 2025
Employees
24,524
Head office
The Heights
Weybridge
United Kingdom
KT13 0NY
mobile
+44 1932959500
letter
investor-relations@haleon.com
computer
Company website

Key personnel

Owner name
chevron-l-regular
chevron-r-regular
Salary
Mr. Alan James Stewart
Senior Independent Director
-
Ms. Blathnaid Bergin
Independent Director
-
Ms. Marie Anne Aymerich
Independent Director
-
Ms. Asmita Dubey
Independent Director
-
Ms. Dawn Allen
Director and Chief Financial Officer
-
Mr. Brian James McNamara
Chief Executive Officer and Director
-
Mr. Manvinder Singh Banga
Chairman of the Board
-

Top 5 shareholders

Owner name
chevron-l-regular
chevron-r-regular
No. of shares
Vanguard342,630,919
Principal Global Investors LLC277,796,551
Massachusetts Financial Services Company217,388,777
Dodge & Cox204,876,304
BlackRock Fund Advisors178,684,206

Director dealings

Date
chevron-l-regular
chevron-r-regular
Action
23 Mar 2026Sale
23 Mar 2026Transfer in
23 Mar 2026Sale
23 Mar 2026Transfer in
23 Sep 2025D
23 Sep 2025D
23 Sep 2025D
18 Sep 2025D
30 Jun 2025Sale
30 Jun 2025Transfer in
30 Jun 2025Sale
30 Jun 2025Transfer in
12 Jun 2025D
10 Jun 2025D
10 Jun 2025D
10 Jun 2025D
05 Jun 2025D
16 May 2025Purchase
Please note that past performance is not a reliable indicator of future returns.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2026 Morningstar. All rights reserved.